Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Sauna Misuse May Lead to Heat Stroke, Data Suggests

Basking in a sauna can be a nice way to relieve stress or relax muscles following a workout. But soaking too long can increase a person s risk of heat stroke, p

Can Exercise Ease Knee Pain? Here's What the Research Shows

but are they right A recent evidence review calls into question just how helpful exercise can be for easing the pain of knee arthritis. Exercise probably result

Non-Opioids Can Ease Post-Dental Surgery Pain Better Than Opioids, Study Shows

Over-the-counter (OTC) drugs acetaminophen and ibuprofen are better at managing dental pain than opioids. People who had their wisdom teeth removed got better r

One in Four Older U.S. Veterans Report Cardiovascular Disease Diagnosis

One in four older U.S. veterans report being diagnosed with cardiovascular disease (CVD) in their lifetime, according to a study published online Dec. 18 in PLO

Study Quantifies Global T2DM, CVD Burdens Attributable to Sugary Drinks

Overall, 9.8 percent of all incident type 2 diabetes (T2D) cases and 3.1 percent of incident cardiovascular disease (CVD) cases were attributable to sugar-sweet

'Sandwich Generation' Caregivers Face Declines in Physical, Mental Health

Sandwich generation caregivers face declines in their own mental and physical health, according to a study published online Jan. 8 in Public Health. Baowen Xue,

Eight in 10 Infants Received RSV Protection in the 2023 to 2024 Season

Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter published online Jan. 8

Medicare Patients Wait Average of 34 Days to See Neurologist After Referral

After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to study published online Jan. 8 in Neurol

GSK’s B7-H3-Targeted Antibody-Drug Conjugate, GSK’227, Receives US FDA Breakthrough Therapy Designation in Late-Line Relapsed or Refractory Osteosarcoma

GSK plc (LSE NYSE GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK 227), its

Johnson & Johnson’s Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer’s Disease

Johnson Johnson (NYSE JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to posdinemab, a phosphorylated t

Popular Keywords